Self-sampling to Optimize Anal Lesion Outcomes
NCT07192055
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either self-sampling or healthcare provider sampling affects clinic attendance.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Anal Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 35 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Medical College of Wisconsin
- Last updated on ClinicalTrials.gov
- May 12, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- University of Chicago · Chicago, IL
Texas · 1
- The University of Texas M.D. Anderson Cancer Center · Houston, TX
Wisconsin · 1
- Medical College of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.